Target intelligence / Profile preview

Transient receptor potential vanilloid 1, Piezo-type mechanosensitive ion channel component 2, and P2X purinoceptor 3 neuroimmune axis (TRPV1/Piezo2/P2X3)

Target
TRPV1/Piezo2/P2X3
Molecular classification
Ion channel, Receptor, Ligand-gated ion channel, Mechanosensitive ion channel
01

Overview

This target complex comprises three distinct ion channels—Transient receptor potential vanilloid 1 (TRPV1), Piezo-type mechanosensitive ion channel component 2 (Piezo2), and P2X purinoceptor 3 (P2X3)—integrated within local neuroimmune pathways. TRPV1 serves as a polymodal sensor for noxious heat, protons, and vanilloids, playing a central role in thermal hyperalgesia (Caterina et al., 1997; UniProt P35497). Piezo2 is the primary transducer of mechanical stimuli, essential for light touch and proprioception, and is implicated in mechanical allodynia (Coste et al., 2010; UniProt Q9H5I5). P2X3 is an ATP-gated channel expressed on sensory neurons that mediates pain and the urge to cough following tissue injury (Burnstock, 2018; UniProt P56373). The interaction of these channels with local neuroimmune pathways involves the release of neuropeptides and cytokines that sensitize peripheral nociceptors, creating a state of chronic hypersensitivity (Pinho-Ribeiro et al., 2017). Pharmacological targeting of this axis, such as through P2X3 antagonists like Gefapixant or TRPV1 agonists like Capsaicin, aims to modulate sensory input to treat conditions like chronic refractory cough and neuropathic pain.

Other names
Nociceptive ion channel complexSensory neuroimmune pathwayPeripheral pain signaling axisTRPV1-Piezo2-P2X3 triad
02

Mechanism of action

Antagonism or desensitization of sensory ion channels to inhibit the transmission of noxious stimuli and disrupt the inflammatory feedback loop between neurons and immune cells.

03

Biological functions

Signal transductionImmune responseNociceptionMechanotransductionThermosensationNeurogenic inflammation
04

Disease associations

Chronic painInflammationChronic coughNeuropathic painOsteoarthritisPruritus
05

Safety considerations

Hyperthermia (TRPV1 inhibition)Impaired noxious heat sensation (TRPV1 inhibition)Dysgeusia or taste disturbance (P2X3 inhibition)Loss of proprioception and light touch (Piezo2 inhibition)
06

Interacting drugs

Capsaicin

5 more in the full profile.

07

Biomarkers

Calcitonin gene-related peptide (CGRP) levelsSubstance PExtracellular ATP concentrationProstaglandin E2 (PGE2)

Beyond the preview

Go deeper on Transient receptor potential vanilloid 1, Piezo-type mechanosensitive ion channel component 2, and P2X purinoceptor 3 neuroimmune axis (TRPV1/Piezo2/P2X3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient receptor potential vanilloid 1, Piezo-type mechanosensitive ion channel component 2, and P2X purinoceptor 3 neuroimmune axis (TRPV1/Piezo2/P2X3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call